{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:33:01Z","timestamp":1782300781794,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jaip.2019.10.048","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T05:08:15Z","timestamp":1586236095000},"page":"1196-1201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome"],"prefix":"10.1016","volume":"8","author":[{"given":"Matthew P.","family":"Giannetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.10.048_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","article-title":"Diagnosis and management of anaphylaxis in precision medicine","volume":"140","author":"Castells","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nri914","article-title":"Regulation of mast-cell and basophil function and survival by IgE","volume":"2","author":"Kawakami","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2019.10.048_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2018.01.034","article-title":"Mast cells signal their importance in health and disease","volume":"142","author":"Olivera","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2014.01.018","article-title":"Mast cell progenitors: origin, development and migration to tissues","volume":"63","author":"Dahlin","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2019.10.048_bib7","series-title":"Biology of mast cells and their mediators. In: Middleton\u2019s allergy: principles and practice. Volumes 1-2","first-page":"228","author":"Bradding","year":"2013"},{"key":"10.1016\/j.jaip.2019.10.048_bib8","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.138.8.2611","article-title":"Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells","volume":"138","author":"Schwartz","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaip.2019.10.048_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.alit.2019.05.009","article-title":"Decreased intracellular histamine concentration and basophil activation in anaphylaxis","volume":"69","author":"Yamaga","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2019.10.048_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaip.2016.11.006","article-title":"Basophil activation test is a relevant biomarker of the outcome of rapid desensitization in platinum compounds-allergy","volume":"5","author":"Giavina-Bianchi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.10.048_bib12","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1182\/blood-2012-09-458521","article-title":"International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis","volume":"121","author":"Gotlib","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.10.048_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.10.048_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.iac.2018.04.002","article-title":"Nonclonal mast cell activation syndrome: a growing body of evidence","volume":"38","author":"Hamilton","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2019.10.048_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","article-title":"Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations","volume":"128","author":"Hamilton","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.1995.00430080119014","article-title":"Idiopathic anaphylaxis: an attempt to estimate the incidence in the United States","volume":"155","author":"Patterson","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2019.10.048_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0091-6749(95)70329-2","article-title":"Underreporting of anaphylaxis in a community emergency room","volume":"95","author":"Klein","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12418","article-title":"Epidemiology of anaphylaxis","volume":"45","author":"Tejedor Alonso","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.10.048_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0091-6749(99)70392-1","article-title":"Epidemiology of anaphylaxis in Olmsted county: a population-based study","volume":"104","author":"Yocum","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis\u2014a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib25","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.anai.2018.07.017","article-title":"The changing face of anaphylaxis in adults and adolescents","volume":"121","author":"Pattanaik","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1081-1206(10)61367-1","article-title":"Anaphylaxis: a review of 601 cases","volume":"97","author":"Webb","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1081-1206(10)63322-4","article-title":"Idiopathic anaphylaxis: a series of 335 cases","volume":"77","author":"Ditto","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1081-1206(10)62014-5","article-title":"Idiopathic anaphylaxis: a descriptive study of 81 patients in Spain","volume":"88","author":"Alonso","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0091-6749(81)90134-2","article-title":"Effects of infused histamine: analysis of the effects of H-1 and H-2 histamine receptor antagonists on cardiovascular and pulmonary responses","volume":"68","author":"Kaliner","year":"1981","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000229815","article-title":"Mechanisms of anaphylaxis in the mouse: similarity of shock induced by anaphylaxis and by mixtures of histamine and serotonin","volume":"40","author":"Iff","year":"1966","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib31","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.jaci.2009.12.981","article-title":"Anaphylaxis","volume":"125","author":"Simons","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib32","first-page":"23","article-title":"Idiopathic anaphylaxis","volume":"2","author":"Greenberger","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.10.048_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaci.2016.03.028","article-title":"IgG subclasses determine pathways of anaphylaxis in mice","volume":"139","author":"Beutier","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1189\/jlb.1212623","article-title":"Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions","volume":"94","author":"J\u00f6nsson","year":"2013","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaip.2019.10.048_bib35","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaci.2005.12.1356","article-title":"Prolonged elevation of serum trytpase in idiopathic anaphylaxis","volume":"117","author":"Shanmugam","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0196-0644(94)70169-5","article-title":"Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature","volume":"24","author":"Tanus","year":"1994","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaip.2019.10.048_bib37","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.138.7.2184","article-title":"Evaluation of human peripheral blood leukocytes for mast cell tryptase","volume":"138","author":"Castells","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib38","first-page":"201","article-title":"The impact of prednisone in life-threatening idiopathic anaphylaxis: reduction in acute episodes and medical costs","volume":"2","author":"Boxer","year":"1989","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2019.10.048_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0091-6749(97)70244-6","article-title":"Pediatric idiopathic anaphylaxis: experience with 22 patients","volume":"100","author":"Ditto","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S1081-1206(10)62547-1","article-title":"Lymphocyte subsets and activation markers in patients with acute episodes of idiopathic anaphylaxis","volume":"85","author":"Grammer","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2500\/108854192778878953","article-title":"Idiopathic anaphylaxis: total experience with 225 patients","volume":"13","author":"Orfan","year":"1992","journal-title":"Allergy Proc"},{"key":"10.1016\/j.jaip.2019.10.048_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2017.06.007","article-title":"Mast cell activation syndromes","volume":"140","author":"Akin","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib43","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.10.048_bib44","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"\u00c1lvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World Allergy Organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2019.10.048_bib47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jaip.2018.11.045","article-title":"Doctor, I think I am suffering from MCAS: differential diagnosis and separating facts from fiction","volume":"7","author":"Valent","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.10.048_bib48","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2019.10.048_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2019.10.048_bib50","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/leu.2015.24","article-title":"KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis","volume":"29","author":"Arock","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2019.10.048_bib51","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/modpathol.2015.72","article-title":"Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications","volume":"28","author":"Jara-Acevedo","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaip.2019.10.048_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000501079","article-title":"Why the 20%\u00a0+ 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome","volume":"180","author":"Valent","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0091-6749(79)90218-5","article-title":"Exercise-induced anaphylactic reaction to shellfish","volume":"63","author":"Maulitz","year":"1979","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11882-018-0830-6","article-title":"Exercise-induced anaphylaxis: literature review and recent updates","volume":"18","author":"Giannetti","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2019.10.048_bib55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A\u00a0distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.10.048_bib56","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/j.jaci.2008.12.563","article-title":"Molecular profiling distinguishes patients with active idiopathic anaphylaxis from normal volunteers and reveals novel aspects of disease biology","volume":"123","author":"Howell","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819309468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819309468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:23:22Z","timestamp":1761974602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219819309468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213219819309468"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.10.048","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.10.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}